These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17943932)

  • 1. Total syntheses of lysobactin (katanosin B).
    Campagne JM
    Angew Chem Int Ed Engl; 2007; 46(45):8548-52. PubMed ID: 17943932
    [No Abstract]   [Full Text] [Related]  

  • 2. Solid-phase synthesis of lysobactin (katanosin B): insights into structure and function.
    Hall EA; Kuru E; VanNieuwenhze MS
    Org Lett; 2012 Jun; 14(11):2730-3. PubMed ID: 22612400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward total solid-phase synthesis of depsipeptide antibiotic katanosin B.
    Stawikowska R; Stawikowski M; Cudic P
    Adv Exp Med Biol; 2009; 611():385-6. PubMed ID: 19400235
    [No Abstract]   [Full Text] [Related]  

  • 4. Total synthesis of lysobactin.
    Guzman-Martinez A; Lamer R; VanNieuwenhze MS
    J Am Chem Soc; 2007 May; 129(18):6017-21. PubMed ID: 17432854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and total synthesis of lysobactin (katanosin B).
    von Nussbaum F; Anlauf S; Benet-Buchholz J; Häbich D; Köbberling J; Musza L; Telser J; Rübsamen-Waigmann H; Brunner NA
    Angew Chem Int Ed Engl; 2007; 46(12):2039-42. PubMed ID: 17211904
    [No Abstract]   [Full Text] [Related]  

  • 6. A concise route to the proposed structure of lydiamycin B, an antimycobacterial depsipeptide.
    Li W; Gan J; Ma D
    Org Lett; 2009 Dec; 11(24):5694-7. PubMed ID: 19919082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the stereochemical assignment of natural lydiamycin A.
    Chen B; Dai L; Zhang H; Tan W; Xu Z; Ye T
    Chem Commun (Camb); 2010 Jan; 46(4):574-6. PubMed ID: 20062866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis of plusbacin A3: a depsipeptide antibiotic active against vancomycin-resistant bacteria.
    Wohlrab A; Lamer R; VanNieuwenhze MS
    J Am Chem Soc; 2007 Apr; 129(14):4175-7. PubMed ID: 17371023
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of Natural and Unnatural Cyclooligomeric Depsipeptides Enabled by Flow Chemistry.
    Lücke D; Dalton T; Ley SV; Wilson ZE
    Chemistry; 2016 Mar; 22(12):4206-17. PubMed ID: 26844421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and assignment of stereochemistry of the antibacterial cyclic peptide xenematide.
    Hung KY; Harris PW; Heapy AM; Brimble MA
    Org Biomol Chem; 2011 Jan; 9(1):236-42. PubMed ID: 20949214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis of NW-G01, a cyclic hexapeptide antibiotic, and 34-epi-NW-G01.
    Shibahara S; Matsubara T; Takahashi K; Ishihara J; Hatakeyama S
    Org Lett; 2011 Sep; 13(17):4700-3. PubMed ID: 21809853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of hormaomycin and one of its all-peptide aza-analogues in solution: syntheses and biological activities of new hormaomycin analogues.
    Reinscheid UM; Zlatopolskiy BD; Griesinger C; Zeeck A; de Meijere A
    Chemistry; 2005 May; 11(10):2929-45. PubMed ID: 15754385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity.
    Walker S; Chen L; Hu Y; Rew Y; Shin D; Boger DL
    Chem Rev; 2005 Feb; 105(2):449-76. PubMed ID: 15700952
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of tripropeptin C derivatives modified at the carboxyl groups.
    Hirosawa S; Takahashi Y; Hashizume H; Miyake T; Akamatsu Y
    J Antibiot (Tokyo); 2014 Mar; 67(3):265-8. PubMed ID: 24301184
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and structure-activity relationship of teixobactin analogues via convergent Ser ligation.
    Jin K; Po KHL; Wang S; Reuven JA; Wai CN; Lau HT; Chan TH; Chen S; Li X
    Bioorg Med Chem; 2017 Sep; 25(18):4990-4995. PubMed ID: 28495382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis and a systematic structure-activity relationship study of WAP-8294A2.
    Chen D; Tian L; Po KHL; Chen S; Li X
    Bioorg Med Chem; 2020 Sep; 28(18):115677. PubMed ID: 32828420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of the lysobactin biosynthetic gene cluster reveals mechanistic insights into an unusual termination module architecture.
    Hou J; Robbel L; Marahiel MA
    Chem Biol; 2011 May; 18(5):655-64. PubMed ID: 21609846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l-allo-enduracididine with its isosteres.
    Parmar A; Iyer A; Lloyd DG; Vincent CS; Prior SH; Madder A; Taylor EJ; Singh I
    Chem Commun (Camb); 2017 Jul; 53(55):7788-7791. PubMed ID: 28650495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopeptidomimetics derived from teixobactin have potent antibacterial activity against Staphylococcus aureus.
    Girt GC; Mahindra A; Al Jabri ZJH; De Ste Croix M; Oggioni MR; Jamieson AG
    Chem Commun (Camb); 2018 Mar; 54(22):2767-2770. PubMed ID: 29484340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of an immobilized digestive enzyme assay to measure chemical and enzymatic hydrolysis of the cyclic peptide antibiotic lysobactin.
    Blackburn RK; Van Breemen RB
    Drug Metab Dispos; 1993; 21(4):573-9. PubMed ID: 8104115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.